SCM
Soleus Capital Management’s Neuropace NPCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.8M | Sell |
2,312,957
-295,211
| -11% | -$3.29M | 1.71% | 18 |
|
|
2025
Q1 | $32.1M | Buy |
2,608,168
+175,000
| +7% | +$2.15M | 2.31% | 11 |
|
|
2024
Q4 | $27.2M | Hold |
2,433,168
| – | – | 1.71% | 17 |
|
|
2024
Q3 | $17M | Hold |
2,433,168
| – | – | 1.31% | 26 |
|
|
2024
Q2 | $18.4M | Hold |
2,433,168
| – | – | 1.62% | 23 |
|
|
2024
Q1 | $32.1M | Hold |
2,433,168
| – | – | 2.38% | 8 |
|
|
2023
Q4 | $25.1M | Sell |
2,433,168
-33,037
| -1% | -$341K | 2.78% | 14 |
|
|
2023
Q3 | $24M | Sell |
2,466,205
-9
| -0% | -$88 | 2.21% | 12 |
|
|
2023
Q2 | $11.1M | Buy |
2,466,214
+37,500
| +2% | +$168K | 1.23% | 23 |
|
|
2023
Q1 | $11.3M | Buy |
2,428,714
+59,711
| +3% | +$277K | 1.17% | 26 |
|
|
2022
Q4 | $3.53M | Buy |
2,369,003
+35,000
| +1% | +$52.2K | 0.51% | 46 |
|
|
2022
Q3 | $8.75M | Hold |
2,334,003
| – | – | 1.19% | 26 |
|
|
2022
Q2 | $11.6M | Buy |
2,334,003
+10,000
| +0.4% | +$49.5K | 1.8% | 18 |
|
|
2022
Q1 | $19.1M | Buy |
2,324,003
+15,000
| +0.6% | +$123K | 2.46% | 11 |
|
|
2021
Q4 | $23.3M | Buy |
2,309,003
+638,867
| +38% | +$6.44M | 2.33% | 9 |
|
|
2021
Q3 | $26.5M | Buy |
1,670,136
+285,749
| +21% | +$4.53M | 4.13% | 6 |
|
|
2021
Q2 | $32.9M | Buy |
+1,384,387
| New | +$32.9M | 5.06% | 4 |
|